The efficacy of compassion focused therapy in eating disorders: a systematic review of the literature
Abstract
Compassion Focused Therapy (CFT) is an evolution-informed intervention designed to address high levels of shame and self-criticism, which are common in eating disorders (EDs). Given the mixed findings of current ED treatments and the absence of prior systematic reviews on CFT in this context, this review aimed to critically evaluate its clinical outcomes. A systematic search of databases was conducted, including PsychINFO, MEDLINE, PubMed, CINAHL, Cochrane Library, and Scopus. Grey literature databases were searched including CORE, PsyArVix Preprints, and BASE. The last search was conducted in February 2025. Studies were included where a quantitative outcome was reported following CFT in participants with any ED diagnosis, across the lifespan. A narrative approach was employed to synthesize the results and the Downs and Black (1998) checklist was used to assess the quality of included studies. Twenty-three studies (8 randomized controlled trials, 2 uncontrolled trials, and 13 quasi-experimental) were included. Eighteen papers were English language, and most participants were adult females. Overall, CFT led to a reduction in ED core psychopathology, including across the EDE-Q subscales, as well as improvements in self-compassion and body image, and a decrease in shame. Evidence for change to body mass index was mixed. Results from trials varied in how effective this treatment was relative to other treatment modalities. There is preliminary evidence to support CFT as an…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.